Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1 with amino acid substitutions at positions 3 and extended half-life (2030 hours vs 10 minutes for endogenous IGF-1), enabling systemic anabolic signaling without growth hormone involvement
Availability is currently limited in Canada, but its an important future option for those seeking an officially approved weight-loss formulation
There was no increased risk of clinically significant or severe hypoglycemic episodes compared to once-daily insulin glargine U100 during the switching approaches [8]
The information guide can be customised for individual hospital use
J Endocr Soc 1(7):965979
USA 110 , 29993004 (2013)
